Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ANTHEM.NSthis companyAnthem Biosciences Ltd.	₹958.15	62.21×	12.1×	17.33×	43.89×	-76.6%	42.1%	32.9%	27.9%	19.5%	16.1%	1.9%	0.02×	-0.26×	101.5×	5.54×	0.0%	5	77.36	1	D+
BLUEJET.NSBlue Jet Healthcare Limited	₹543.55	22.9×	4.17×	5.99×	18.93×	-77.2%	43.7%	28.5%	26.2%	18.2%	14.2%	0.0%	0.03×	-0.36×	43.29×	4.21×	0.4%	3	—	2	C
COHANCE.NSCohance Lifesciences Limited	₹443.65	64.28×	2.95×	5.08×	27.48×	-9.7%	40.2%	10.6%	7.9%	4.6%	3.3%	1.2%	0.1×	0.79×	6.44×	2.78×	0.0%	6	9.25	3	B
CONCORDBIO.NSConcord Biotech Limited	₹596.80	41.1×	5.32×	10.16×	25.54×	-74.8%	41.9%	27.8%	24.7%	12.9%	10.7%	1.6%	0×	-0.03×	1,034.4×	7.39×	1.0%	3	30.82	3	B+
DCAL.NSDishman Carbogen Amcis Limited	₹167.10	20.9×	0.3×	0.69×	7.34×	-102.0%	25.2%	7.6%	3.3%	1.5%	1.9%	3.8%	0.46×	3.71×	1.28×	1.23×	0.0%	3	—	2	C
JUBLPHARMA.NSJubilant Pharmova Limited	₹966.00	32.46×	1.82×	1.56×	12.07×	-242.1%	30.1%	9.9%	4.8%	5.6%	4.0%	-3.4%	0.51×	1.85×	3.87×	1.62×	0.6%	5	—	2	C
Peer median	—	32.46×	2.95×	5.08×	18.93×	-77.2%	40.2%	10.6%	7.9%	5.6%	4.0%	1.2%	0.1×	0.79×	6.44×	2.78×	0.4%	3	20.03	2	—